Eagle Pharmaceuticals
EGRX
$4.77
Share price
4.41%
Change (1 day)
-83.65%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) Fails to deliver data
Key failure to deliver metrics for Eagle Pharmaceuticals :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.74 M
- Last year FTD volume: $1.83 M
Failures to deliver for Eagle Pharmaceuticals (EGRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Eagle Pharmaceuticals (EGRX) - since 2014
Volume in USD (price x number of shares), data since 2014Eagle Pharmaceuticals (EGRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.74 M | -72.53% |
| 2023 | $2.72 M | -41.7% |
| 2022 | $4.67 M | 3.14% |
| 2021 | $4.53 M | -45.05% |
| 2020 | $8.25 M | 289.43% |
| 2019 | $2.12 M | -87.17% |
| 2018 | $16.52 M | -39.82% |
| 2017 | $27.46 M | -62.01% |
| 2016 | $72.29 M | 483.08% |
| 2015 | $12.39 M | -5.92% |
| 2014 | $13.17 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $30.58 M | $84.43 M | 🇨🇭 Switzerland |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $62.04 M | $0.18 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.24 M | $23.04 M | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $6.83 M | $36.36 M | 🇮🇱 Israel |